Moonpig Support Lifesavers

8th February 2021


Moonpig, the leading online destination for greetings cards, gifts and flowers are supporting Cure Leukaemia with its Lifesavers 100 Club campaign by producing the personalised 100 Club cards sent to members when they have reached their £100 fundraising goal.

The Lifesavers 100 Club was created to empower the charity’s supporters by highlighting that £100 raised can make a huge difference and help the save lives of blood cancer patients across the UK. Supporters are encouraged to raise a minimum of £100 in whatever way they choose whether that is through a physical challenge, a regular donation, barbecue or cake sale. 

When they have reached their £100 target, their membership in the 100 Club will be confirmed with a personalised Moonpig card with their photo included and a medal in recognition of their achievement.

David Rimmer, Moonpig Commercial Director said:

"We're delighted to support Cure Leukaemia with their initiative to use cards to say thank you to all of their amazing 100 Club Lifesavers. In a time when a lot of us are apart, we hope that we can help bring people together for such an important cause."

James McLaughlin, Cure Leukaemia CEO commented:

“We are so grateful to Moonpig for giving us the platform to personalise our appreciation for every member of the Lifesavers 100 Club. Every £100 raised for Cure Leukaemia does directly help save lives and we hope that these cards will emphasise our gratitude to all who fundraise for us and instil a sense of pride in all our supporters for their achievement.”

To find out more about the Cure Leukaemia Lifesavers 100 Club email lifesavers@cureleukaemia.co.uk.

< Back to List

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell